• Chinese consortium to acquire German pharma firm AMW pharmaceutical-technology
    July 12, 2018
    Germany-based drug delivery systems developer AMW has signed an agreement to be acquired by a consortium led by private equity firm Yunfeng (YF) Capital and Chinese drug developer Hybio Pharmaceutical.
PharmaSources Customer Service